Subtle retinal pathology in amyotrophic lateral sclerosis

Annals of Clinical and Translational Neurology

Volumn 1, Issue 4, 2014, Pages 290-297

  Ringelstein, Marius ^a   Albrecht, Philipp ^a   Südmeyer, Martin ^a   Harmel, Jens ^a   Müller, Ann Kristin ^a   Keser, Nazmiye ^a   Finis, David ^a   Ferrea, Stefano ^a   Guthoff, Rainer ^a   Schnitzler, Alfons ^a   Hartung, Hans Peter ^a   Methner, Axel ^a,b   Aktas, Orhan ^a  

^a Department of Orthopedic Surgery   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

RILUZOLE;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BEST CORRECTED VISUAL ACUITY; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; EYE MOVEMENT CONTROL; FEMALE; HUMAN; IMAGE SEGMENTATION; INTERRATER RELIABILITY; MACULAR THICKNESS; MALE; NERVE DEGENERATION; OCULOPLETHYSMOGRAPHY; OPHTHALMOSCOPY; PRIORITY JOURNAL; QUALITY CONTROL; REPRODUCIBILITY; RETINA INJURY; RETINAL INNER NUCLEAR LAYER; RETINAL NERVE FIBER LAYER THICKNESS; RETINAL OUTER NUCLEAR LAYER; RETINAL OUTER PLEXIFORM LAYER; SLIT LAMP MICROSCOPY; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; VERY ELDERLY; VISUAL ACUITY; VISUAL EVOKED POTENTIAL;

EID: 84938920063     PISSN: None     EISSN: 23289503     Source Type: Journal    
DOI: 10.1002/acn3.46     Document Type: Article

References (32)

1. Kiernan MC, Vucic S, Cheah BC, et al. Amyotrophic lateral sclerosis. Lancet 2011;377:942–955.
2. Ludolph AC, Brettschneider J, Weishaupt JH. Amyotrophic lateral sclerosis. Curr Opin Neurol 2012;25:530–535.
3. Brettschneider J, Del TK, Toledo JB, et al. Stages of pTDP-43 pathology in amyotrophic lateral sclerosis. Ann Neurol 2013;74:20–38.
4. Sharma R, Hicks S, Berna CM, et al. Oculomotor dysfunction in amyotrophic lateral sclerosis: a comprehensive review. Arch Neurol 2011;68:857–861.
5. Moss HE, McCluskey L, Elman L, et al. Cross-sectional evaluation of clinical neuro-ophthalmic abnormalities in an amyotrophic lateral sclerosis population. J Neurol Sci 2012;314:97–101.
6. Munte TF, Troger MC, Nusser I, et al. Alteration of early components of the visual evoked potential in amyotrophic lateral sclerosis. J Neurol 1998;245:206–210.
7. Bede P, Bokde A, Elamin M, et al. Grey matter correlates of clinical variables in amyotrophic lateral sclerosis (ALS): a neuroimaging study of ALS motor phenotype heterogeneity and cortical focality. J Neurol Neurosurg Psychiatry 2013;84:766–773.
8. Drexler W, Morgner U, Ghanta RK, et al. Ultrahigh-resolution ophthalmic optical coherence tomography. Nat Med 2001;7:502–507.
9. Gelfand JM, Goodin DS, Boscardin WJ, et al. Retinal axonal loss begins early in the course of multiple sclerosis and is similar between progressive phenotypes. PLoS ONE 2012;7:e36847.
10. Walter SD, Ishikawa H, Galetta KM, et al. Ganglion cell loss in relation to visual disability in multiple sclerosis. Ophthalmology 2012;119:1250–1257.
11. Saidha S, Syc SB, Ibrahim MA, et al. Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography. Brain 2011;134:518–533.
12. Albrecht P, Ringelstein M, Muller AK, et al. Degeneration of retinal layers in multiple sclerosis subtypes quantified by optical coherence tomography. Mult Scler 2012;18:1422–1429.
13. Albrecht P, Muller AK, Sudmeyer M, et al. Optical coherence tomography in parkinsonian syndromes. PLoS ONE 2012;7:e34891.
14. Albrecht P, Muller AK, Ringelstein M, et al. Retinal neurodegeneration in Wilson's disease revealed by spectral domain optical coherence tomography. PLoS ONE 2012;7:e49825.
15. Kesler A, Vakhapova V, Korczyn AD, et al. Retinal thickness in patients with mild cognitive impairment and Alzheimer's disease. Clin Neurol Neurosurg 2011;113:523–526.
16. De Carvalho M, Dengler R, Eisen A, et al. Electrodiagnostic criteria for diagnosis of ALS. Clin Neurophysiol 2008;119:497–503.
17. Tewarie P, Balk L, Costello F, et al. The OSCAR-IB consensus criteria for retinal OCT quality assessment. PLoS ONE 2012;7:e34823.
18. Seigo MA, Sotirchos ES, Newsome S, et al. In vivo assessment of retinal neuronal layers in multiple sclerosis with manual and automated optical coherence tomography segmentation techniques. J Neurol 2012;259:2119–2130.
19. van Swieten JC, Koudstaal PJ, Visser MC, et al. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988;19:604–607.
20. Abraham A, Drory VE. Fatigue in motor neuron diseases. Neuromuscul Disord 2012;22(Suppl 3):S198–S202.
21. Olney NT, Goodkind MS, Lomen-Hoerth C, et al. Behaviour, physiology and experience of pathological laughing and crying in amyotrophic lateral sclerosis. Brain 2011;134:3458–3469.
22. Weis J, Katona I, Muller-Newen G, et al. Small-fiber neuropathy in patients with ALS. Neurology 2011;76:2024–2029.
23. Phukan J, Elamin M, Bede P, et al. The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study. J Neurol Neurosurg Psychiatry 2012;83:102–108.
24. Kielczewski JL, Pease ME, Quigley HA. The effect of experimental glaucoma and optic nerve transection on amacrine cells in the rat retina. Invest Ophthalmol Vis Sci 2005;46:3188–3196.
25. Park HY, Park YG, Cho AH, et al. Transneuronal retrograde degeneration of the retinal ganglion cells in patients with cerebral infarction. Ophthalmology 2013;120:1292–1299.
26. Saidha S, Sotirchos ES, Ibrahim MA, et al. Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study. Lancet Neurol 2012;11:963–972.
27. Kaufhold F, Zimmermann H, Schneider E, et al. Optic neuritis is associated with inner nuclear layer thickening and microcystic macular edema independently of multiple sclerosis. PLoS ONE 2013;8:e71145.
28. Brandt AU, Oberwahrenbrock T, Ringelstein M, et al. Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography. Brain 2011;134:e193.
29. Green AJ, McQuaid S, Hauser SL, et al. Ocular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease duration. Brain 2010;133:1591–1601.
30. Roth NM, Saidha S, Zimmermann H, et al. Optical coherence tomography does not support optic nerve involvement in amyotrophic lateral sclerosis. Eur J Neurol 2013;20:1170–1176.
31. Wexler A, Sand T, Elsas TB. Macular thickness measurements in healthy Norwegian volunteers: an optical coherence tomography study. BMC Ophthalmol 2010;10:13.
32. Cedarbaum JM, Stambler N, Malta E, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci 1999;169:13–21.